Literature DB >> 25195069

Using positron emission tomography to study human ketone body metabolism: a review.

Nadia Bouteldja1, Lone Thing Andersen2, Niels Møller3, Lars Christian Gormsen4.   

Abstract

Ketone bodies - 3-hydroxybutyrate and acetoacetate - are important fuel substrates, which can be oxidized by most tissues in the body. They are synthesized in the liver and are derived from fatty acids released from adipose tissue. Intriguingly, under conditions of stress such as fasting, arterio-venous catheterization studies have shown that the brain switches from the use of almost 100% glucose to the use of >50-60% ketone bodies. A similar adaptive mechanism is observed in the heart, where fasting induces a shift toward ketone body uptake that provides the myocardium with an alternate fuel source and also favorably affects myocardial contractility. Within the past years there has been a renewed interest in ketone bodies and the possible beneficial effects of fasting/semi-fasting/exercising and other "ketogenic" regimens have received much attention. In this perspective, it is promising that positron emission tomography (PET) techniques with isotopically labeled ketone bodies, fatty acids and glucose offer an opportunity to study interactions between ketone body, fatty acid and glucose metabolism in tissues such as the brain and heart. PET scans are non-invasive and thus eliminates the need to place catheters in vascular territories not easily accessible. The short half-life of e.g. 11C-labeled PET tracers even allows multiple scans on the same study day and reduces the total radiation burden associated with the procedure. This short review aims to give an overview of current knowledge on ketone body metabolism obtained by PET studies and discusses the methodological challenges and perspectives involved in PET ketone body research.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac metabolism; Fasting; Ketone bodies; PET

Mesh:

Substances:

Year:  2014        PMID: 25195069     DOI: 10.1016/j.metabol.2014.08.001

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  [Quality management in weight restitution in Anorexia nervosa--pathophysiology, evidence-based practice and prevention of the refeeding syndrome].

Authors:  Michael Mayr; Hartmut Imgart; Katrin Skala; Andreas Karwautz
Journal:  Neuropsychiatr       Date:  2015-11-23

2.  Synthesis and in vivo evaluation of a radiofluorinated ketone body derivative.

Authors:  Stephanie J Mattingly; Melinda Wuest; Eugene J Fine; Ralf Schirrmacher; Frank Wuest
Journal:  RSC Med Chem       Date:  2020-02-13

3.  Modulation of cerebral ketone metabolism following traumatic brain injury in humans.

Authors:  Adriano Bernini; Mojgan Masoodi; Daria Solari; John-Paul Miroz; Laurent Carteron; Nicolas Christinat; Paola Morelli; Maurice Beaumont; Samia Abed-Maillard; Mickael Hartweg; Fabien Foltzer; Philippe Eckert; Bernard Cuenoud; Mauro Oddo
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

4.  Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Myriam Abboud; Fatme AlAnouti; Evridiki Georgaki; Dimitrios Papandreou
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

Review 5.  Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies.

Authors:  Hanne M M Rooijackers; Evita C Wiegers; Cees J Tack; Marinette van der Graaf; Bastiaan E de Galan
Journal:  Cell Mol Life Sci       Date:  2015-10-31       Impact factor: 9.261

6.  Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial.

Authors:  Mads Svart; Lars C Gormsen; Jakob Hansen; Dora Zeidler; Michael Gejl; Kim Vang; Joel Aanerud; Niels Moeller
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

7.  Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.

Authors:  Willemijn J van Rijt; Emmalie A Jager; Derk P Allersma; A Çiğdem Aktuğlu Zeybek; Kaustuv Bhattacharya; François-Guillaume Debray; Carolyn J Ellaway; Matthias Gautschi; Michael T Geraghty; David Gil-Ortega; Austin A Larson; Francesca Moore; Eva Morava; Andrew A Morris; Kimihiko Oishi; Manuel Schiff; Sabine Scholl-Bürgi; Michel C Tchan; Jerry Vockley; Peter Witters; Saskia B Wortmann; Francjan van Spronsen; Johan L K Van Hove; Terry G J Derks
Journal:  Genet Med       Date:  2020-01-06       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.